Effects of Passive Smoking on Children During Gastrointestinal Endoscopy

Sponsor
TC Erciyes University (Other)
Overall Status
Completed
CT.gov ID
NCT03920046
Collaborator
(none)
518
1
25.9
20

Study Details

Study Description

Brief Summary

To evaluate the effect of passive smoking in children during Gastrointestinal Endoscopy.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Control Group

Detailed Description

When the patients and their parents are arrived in the endoscopy unıt about 1 h before the procedure, the anesthetist is obtained a medical history and carried out a physical examination and clinical assesment. Then the parents smoking habits are documented about to detect the magnitude of passive smoking. Endoscopist and anesthesiologist are blinded to the patients passive smoking history. Then the sedation is applied and esophagogastroduodenoscopy procedures performed. Side effects (e.g laryngospasm, coughing) during the study are recorded.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
518 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Effects of Passive Smoking on Children During Gastrointestinal Endoscopy
Actual Study Start Date :
Jan 2, 2019
Actual Primary Completion Date :
Mar 1, 2021
Actual Study Completion Date :
Mar 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Effects of passive smoking on children

The prevalence of laryngospasm in sedation applied to endoscopic intervention whose parents smoking.

Behavioral: Control Group
The prevalence of laryngospasm in sedation applied to endoscopic intervention whose parents no smoking.

Outcome Measures

Primary Outcome Measures

  1. laryngospasm ratio [an average of 2 hours]

    The prevalence of laryngospasm in sedation applied to endoscopic intervention whose parents smoking.

Secondary Outcome Measures

  1. hypoxia ratio (oxygen saturation < % 90) [an average of 2 hours]

    The prevalence of hypoxia (oxygen saturation < % 90) in sedation applied to endoscopic intervention whose parents smoking.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Year to 18 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • ASA ( American Society of Anesthesiologists) I- ASA II patients

  • Aged 1- 18 Year old patients

Exclusion Criteria:
  • Smoker patients

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sibel Seçkin Pehlivan Kayseri Talas Turkey 38039

Sponsors and Collaborators

  • TC Erciyes University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Sibel Seçkin Pehlivan, Teaching Assistant, TC Erciyes University
ClinicalTrials.gov Identifier:
NCT03920046
Other Study ID Numbers:
  • 2018/641
First Posted:
Apr 18, 2019
Last Update Posted:
Mar 16, 2021
Last Verified:
Mar 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Sibel Seçkin Pehlivan, Teaching Assistant, TC Erciyes University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 16, 2021